Fulgent Genetics, Inc. FLGT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 38.7%-1.8pp | 40.6%-0.7pp | 41.2%+1.2pp | 40%+1.2pp | 38.8%+1.0pp | |
| Operating margin | -33.1%-4.8pp | -28.2%-5.7pp | -22.5%+1.5pp | -24%+0.6pp | -24.6%+1.5pp | |
| Net margin | -23%-4.3pp | -18.8%-5.1pp | -13.6%+3.2pp | -16.8%-2.9pp | -13.9%+1.1pp | |
| EBITDA margin | -25.5%-4.8pp | -20.8%-5.9pp | -14.8%+1.2pp | -16%+0.3pp | -16.3%+1.0pp | |
| Free cash flow margin | -36.9%+3.2pp | -40.1%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | -6.8%-1.4pp | -5.4%-1.6pp | -3.8%+0.7pp | -4.5%-0.9pp | -3.6%+0.2pp | |
| Return on assets | -6.2%-1.3pp | -5%-1.5pp | -3.5%+0.7pp | -4.2%-0.8pp | -3.3%+0.1pp | |
| Return on invested capital | -10.1%-1.6pp | -8.5%-1.7pp | -6.8%+0.1pp | -6.9%-0.2pp | -6.7%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 5.3×-1.2× | 6.5×-0.5× | 7×+1.0× | 6×-0.3× | 6.3×+1.5× | |
| Quick ratio | 5.3×-1.2× | 6.5×-0.5× | 7×+1.0× | 6×-0.3× | 6.3×+1.5× | |
| Cash ratio | 0.3×-0.3× | 0.6×-1.0× | 1.6×+0.4× | 1.2×+0.2× | 1×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -1,358×-143× | -1,214.6×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $34.00-5.9% | $36.13-1.3% | $36.62+0.2% | $36.560.0% | $36.56-2.5% | |
| Valuation | ||||||
| Market capitalization | $552.11M-7.1% | $812.07M+17.4% | $691.76M+16.4% | $594.26M+13.9% | $521.63M-7.7% | |
| Enterprise value | $536.92M+0.7% | $767.48M+32.4% | $579.68M+13.2% | $511.87M+11.2% | $460.19M-10.8% | |
| Price / sales | 1.7×-0.3× | 2.5×+0.3× | 2.2×+0.2× | 2×+0.2× | 1.8×-0.2× | |
| Price / book | 0.5×0.0× | 0.7×+0.1× | 0.6×+0.1× | 0.5×+0.1× | 0.5×0.0× | |
| EV / sales | 1.7×-0.1× | 2.4×+0.5× | 1.8×+0.1× | 1.7×+0.1× | 1.6×-0.2× | |
| Free cash flow yield | -21.4%— | -15.9%— | —— | —— | —— | |
| Earnings yield | -13.4%-6.5pp | -7.5%-1.2pp | -6.2%+2.4pp | -8.6%-0.8pp | -7.8%-0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Fulgent Genetics, Inc.'s profit margins?
- Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
- Where do Fulgent Genetics, Inc.'s ratios come from?
- Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
